Stocks and Investing Stocks and Investing
Mon, November 15, 2021
Fri, November 12, 2021

Douglas Tsao Maintained (TXMD) at Strong Buy with Decreased Target to $150 on, Nov 12th, 2021


Published on 2024-10-27 18:38:12 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Decreased Target from $200 to $150 on, Nov 12th, 2021.

Douglas, nor any peers, have made any analyst calls on TXMD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources